Movatterモバイル変換

[0]ホーム
URL:

ES2075148T3 - Acido alfa-glicosil-l-ascorbico, y su preparacion y usos. - Google Patents

Acido alfa-glicosil-l-ascorbico, y su preparacion y usos.

Info

Publication number
ES2075148T3
ES2075148T3ES90303484TES90303484TES2075148T3ES 2075148 T3ES2075148 T3ES 2075148T3ES 90303484 TES90303484 TES 90303484TES 90303484 TES90303484 TES 90303484TES 2075148 T3ES2075148 T3ES 2075148T3
Authority
ES
Spain
Prior art keywords
ascorbic acid
alpha
glycosyl
preparation
saccharide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90303484T
Other languages
English (en)
Inventor
Itaru Yamamoto
Norio Muto
Toshio Miyake
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hayashibara Seibutsu Kagaku Kenkyujo KK
Original Assignee
Hayashibara Seibutsu Kagaku Kenkyujo KK
Hayashibara Biochemical Laboratories Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP1274518Aexternal-prioritypatent/JP2926412B2/ja
Application filed by Hayashibara Seibutsu Kagaku Kenkyujo KK, Hayashibara Biochemical Laboratories Co LtdfiledCriticalHayashibara Seibutsu Kagaku Kenkyujo KK
Application grantedgrantedCritical
Publication of ES2075148T3publicationCriticalpatent/ES2075148T3/es
Anticipated expirationlegal-statusCritical
Expired - Lifetimelegal-statusCriticalCurrent

Links

Classifications

Landscapes

Abstract

EL ACIDO ASCORBICO ALFA-GLICOSIL-L SE FORMA EN UNA SOLUCION CONTENIENDO ACIDO ASCORBICO L Y UN SACARIDO ALFA-GLUCOSIL, CUANDO ESTA SUJETO A LA ACCION DE UNA ENZIMA TRANSFERENTE DE LOS SACARIDOS. EL ACIDO ASCORBICO ALFA -GLICOSIL-L ES ESTABLE Y FACILMENTE HIDROLIZABLE IN VIVO. ASI, EL ACIDO ASCORBICO ALFA- GLICOSIL-L ES EMPLEADO EN LA INDUSTRIA FARMACEUTICA Y COSMETICA COMO ESTABILIZADOR, COMO AGENTE MEJORADOR DE LA CALIDAD, COMO ANTIOXIDANTE, COMO AGENTE FISIOLOGICAMENTE ACTIVO Y ABSORBEDOR DE RAYOS ULTRAVIOLETA.
ES90303484T1989-05-191990-03-30Acido alfa-glicosil-l-ascorbico, y su preparacion y usos.Expired - LifetimeES2075148T3 (es)

Applications Claiming Priority (2)

Application NumberPriority DateFiling DateTitle
JP127072891989-05-19
JP1274518AJP2926412B2 (ja)1989-05-191989-10-20α―グリコシル―Ｌ―アスコルビン酸とその製造方法並びに用途

Publications (1)

Publication NumberPublication Date
ES2075148T3true ES2075148T3 (es)1995-10-01

Family

ID=26463107

Family Applications (1)

Application NumberTitlePriority DateFiling Date
ES90303484TExpired - LifetimeES2075148T3 (es)1989-05-191990-03-30Acido alfa-glicosil-l-ascorbico, y su preparacion y usos.

Country Status (7)

CountryLink
US (3)US5137723A (es)
EP (1)EP0398484B1 (es)
AT (1)ATE123306T1 (es)
DE (1)DE69019779T2 (es)
DK (1)DK0398484T3 (es)
ES (1)ES2075148T3 (es)
HK (1)HK111196A (es)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US5137723A (en)*1989-05-191992-08-11Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujoα-Glycosyl-L-ascorbic acid, and its preparation and uses
JP2832848B2 (ja)*1989-10-211998-12-09株式会社林原生物化学研究所結晶２―Ｏ―α―Ｄ―グルコピラノシル―Ｌ―アスコルビン酸とその製造方法並びに用途
JP2926432B2 (ja)*1990-06-111999-07-28株式会社林原生物化学研究所養毛剤
TW197375B (es)*1990-11-191993-01-01Hayashibara Biochem Lab
US5215767A (en)*1991-03-161993-06-01Kabushiki Kaisha Hayashibara Seibutsu Kagaku KenkyujoAdditive for aquaculture feed for fish and shellfish and aquaculture feed for fish and shellfish which contains same
US5272136A (en)*1991-10-121993-12-21Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo5-0-α-D-Glucopyranosyl-L-ascorbic acid, and its preparation and uses
JP3072535B2 (ja)*1991-10-212000-07-31株式会社林原生物化学研究所５−Ｏ−α−Ｄ−グルコピラノシル−Ｌ−アスコルビン酸とその製造方法並びに用途
JP3134235B2 (ja)*1991-10-232001-02-13株式会社林原生物化学研究所２−Ｏ−α−Ｄ−グルコピラノシル−Ｌ−アスコルビン酸高含有物の製造方法
US5314678A (en)*1992-01-281994-05-24Mallinckrodt Medical, Inc.Sodium iodide 131 I capsules
JP3134236B2 (ja)*1992-01-302001-02-13株式会社林原生物化学研究所α−グリコシル−Ｌ−アスコルビン酸高含有物の製造方法とその製造のための分離システム
CA2091616C (en)*1992-03-172002-11-26Ryuzo UenoMethod for manufacturing powdery crystalline maltitol
DE69428322T2 (de)*1993-10-262002-06-20Shiseido Co. Ltd., Tokio/TokyoHautbleichende Mittel enthaltend Glykoside
US5455035A (en)*1994-01-131995-10-03Elizabeth Arden Company, Division Of Conopco, Inc.Clear two-phase cosmetic composition
US5935584A (en)*1994-01-131999-08-10Elizabeth Arden CompanyVitamin C delivery system
GB9403855D0 (en)*1994-03-011994-04-20Scotia Holdings PlcFatty acid derivatives
US5837222A (en)*1994-06-101998-11-17Cloonan; Richard A.Liquid dental cleaning solution
US5573398A (en)*1994-06-101996-11-12Towle; Lawrence E.Dental hygiene device and cleaning solution
US6224376B1 (en)1994-06-102001-05-01Richard A. CloonanDental cleaning liquid and gel
FR2733148B1 (fr)*1995-04-201997-05-30OrealComposition pour lutter contre les taches et/ou le vieillissement de la peau, ses utilisations
US5750123A (en)*1996-06-281998-05-12Chesebrough-Pond's Co., Division Of Conopco, Inc.Vitamin C delivery system
JP4981198B2 (ja)1998-03-312012-07-18格 山本グリコシル−ｌ−アスコルビン酸のアシル化誘導体
US6656920B2 (en)2000-04-042003-12-02Amarillo Biosciences, Inc.Composition and method for promoting oral health
FR2807322B1 (fr)2000-04-102004-02-20OrealComposition, notamment cosmetique, comprenant de l'acide ascorbique en association avec un derive d'acide ascorbique
FR2807320B1 (fr)*2000-04-102002-05-24OrealUtilisation de derives d'acide ascorbique pour augmenter la synthese des creramides epidermiques
JP2002326924A (ja)*2001-05-072002-11-15Hayashibara Biochem Lab Inc洗顔料
KR100440191B1 (ko)*2001-08-232004-07-12박관화항산화 효과 및 높은 안정성을 갖는 아스코르브산 유도체및 그것의 제조방법
KR100440190B1 (ko)*2001-08-232004-07-12박관화아카비오신-글루코실 아스코르베이트 및 그의 제조방법
FR2834641B1 (fr)*2002-01-142005-04-22Ct Regional De Lutte Contre LeProtection de la neurotoxicite de l'oxaliplatine par administration de calcium et de magnesium
KR20030080869A (ko)*2002-04-112003-10-17주식회사 코리아나화장품아스코르브산 2-글루코시드를 포함하는 피부 미백용화장료 조성물
JP4043312B2 (ja)*2002-08-062008-02-06株式会社林原生物化学研究所２−Ｏ−α−Ｄ−グルコピラノシル−Ｌ−アスコルビン酸の製造方法
KR20040038438A (ko)*2002-11-012004-05-08주식회사 코리아나화장품아스코르브산 2-글루코시드 및 송이 추출물을 포함하는피부 미백용 화장료 조성물
FR2861734B1 (fr)2003-04-102006-04-14Corneal IndReticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
KR100511419B1 (ko)*2003-09-152005-08-30한국생명공학연구원베타-프럭토실-엘-아스코르브산 및 그의 제조방법
WO2006079212A1 (en)*2005-01-262006-08-03Diamedica Inc.Use of s-adenosylmethionme, vitamin e, and vitamin c for the treatment of oxidative liver injury or insulin resistance
JP4766653B2 (ja)*2005-01-282011-09-07株式会社林原生物化学研究所眼科用医薬組成物
WO2006090939A1 (en)*2005-02-232006-08-31Bioland Ltd.Cosmetic composition comprising beta-fructosyl-l-ascorbic acid for skin whitening
MX2007011784A (es)*2005-03-232008-03-14Mary Kay IncComposiciones para aclarar la piel.
WO2006137129A1 (ja)*2005-06-212006-12-28Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo皮膚外用剤
KR100691540B1 (ko)*2006-06-222007-03-12주식회사 펩트론펩타이드가 결합된 안정화된 비타민 ｃ 유도체, 이의제조방법 및 이를 함유하는 조성물
EP2129231A4 (en)*2007-02-012015-01-21Nat Res Council Canada FORMULATIONS LIPOPHILER BIOACTIVE MOLECULES
AU2008256819A1 (en)*2007-05-232008-12-04Allergan, Inc.Cross-linked collagen and uses thereof
US8318695B2 (en)*2007-07-302012-11-27Allergan, Inc.Tunably crosslinked polysaccharide compositions
JP5336494B2 (ja)*2007-09-142013-11-06南京中▲獅▼▲化▼学品有限公司アスコルビン酸誘導体、その製造方法並びに係る中間体及びその誘導体の化粧品における利用
US8697044B2 (en)2007-10-092014-04-15Allergan, Inc.Crossed-linked hyaluronic acid and collagen and uses thereof
TR201901431T4 (tr)2007-11-162019-02-21Aclaris Therapeutics IncPurpura tedavisi için bileşimler ve yöntemler.
US20090143348A1 (en)*2007-11-302009-06-04Ahmet TezelPolysaccharide gel compositions and methods for sustained delivery of drugs
US8394784B2 (en)*2007-11-302013-03-12Allergan, Inc.Polysaccharide gel formulation having multi-stage bioactive agent delivery
US8394782B2 (en)*2007-11-302013-03-12Allergan, Inc.Polysaccharide gel formulation having increased longevity
US8357795B2 (en)*2008-08-042013-01-22Allergan, Inc.Hyaluronic acid-based gels including lidocaine
WO2010028025A1 (en)2008-09-022010-03-11Gurtner Geoffrey CThreads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
JP4885245B2 (ja)*2009-01-152012-02-29日本航空電子工業株式会社Ｒｄコンバータ及び角度検出装置
RU2532671C2 (ru)*2009-09-032014-11-10Хаясибара Ко.,Лтд.ПРЕПАРАТ В ВИДЕ ТВЕРДЫХ ЧАСТИЦ ДИСПЕРСНОЙ ФАЗЫ, СОДЕРЖАЩИЙ БЕЗВОДНУЮ КРИСТАЛЛИЧЕСКУЮ 2-О-α-D-ГЛЮКОЗИЛ-L-АСКОРБИНОВУЮ КИСЛОТУ, СПОСОБ ЕГО ПРОИЗВОДСТВА И ЕГО ПРИМЕНЕНИЯ
AU2010293447B2 (en)*2009-09-142013-07-04National University Corporation Hokkaido UniversityAnti-plant-virus agent
US8927043B2 (en)*2009-11-102015-01-06Mycell TechnologiesStabilized formulations of fatty acids
US20110171286A1 (en)*2010-01-132011-07-14Allergan, Inc.Hyaluronic acid compositions for dermatological use
US20110171311A1 (en)*2010-01-132011-07-14Allergan Industrie, SasStable hydrogel compositions including additives
US9114188B2 (en)2010-01-132015-08-25Allergan, Industrie, S.A.S.Stable hydrogel compositions including additives
US20110172180A1 (en)2010-01-132011-07-14Allergan Industrie. SasHeat stable hyaluronic acid compositions for dermatological use
US20110171310A1 (en)*2010-01-132011-07-14Allergan Industrie, SasHydrogel compositions comprising vasoconstricting and anti-hemorrhagic agents for dermatological use
US8586562B2 (en)2010-03-122013-11-19Allergan Industrie, SasFluid compositions for improving skin conditions
EP3078388B1 (en)2010-03-222019-02-20Allergan, Inc.Cross-linked hydrogels for soft tissue augmentation
US8883139B2 (en)2010-08-192014-11-11Allergan Inc.Compositions and soft tissue replacement methods
US9005605B2 (en)2010-08-192015-04-14Allergan, Inc.Compositions and soft tissue replacement methods
US8697057B2 (en)2010-08-192014-04-15Allergan, Inc.Compositions and soft tissue replacement methods
US8889123B2 (en)2010-08-192014-11-18Allergan, Inc.Compositions and soft tissue replacement methods
KR101957665B1 (ko)2011-03-072019-03-13가부시기가이샤하야시바라2-O-α-D-글루코실-L-아스코르빈산 무수결정 함유 분말의 제조방법
US20130096081A1 (en)2011-06-032013-04-18Allergan, Inc.Dermal filler compositions
US9408797B2 (en)2011-06-032016-08-09Allergan, Inc.Dermal filler compositions for fine line treatment
US9393263B2 (en)2011-06-032016-07-19Allergan, Inc.Dermal filler compositions including antioxidants
EP3536307B1 (en)2011-06-032021-10-20ALLERGAN Industrie, SASDermal filler compositions including antioxidants
EP2747747B1 (en)2011-08-252019-12-18ALLERGAN Industrie, SASDermal filler compositions including antioxidants
US20130244943A1 (en)2011-09-062013-09-19Allergan, Inc.Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
US9662422B2 (en)2011-09-062017-05-30Allergan, Inc.Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
WO2014103475A1 (ja)2012-12-272014-07-03株式会社林原アンチエイジング用皮膚外用組成物及びその製造方法
CN103755756B (zh)*2014-02-112015-07-08江苏诚信药业有限公司一种制备维生素c葡萄糖苷的工艺系统及其工艺方法
WO2016051219A1 (en)2014-09-302016-04-07Allergan Industrie, SasStable hydrogel compositions including additives
WO2016128783A1 (en)2015-02-092016-08-18Allergan Industrie SasCompositions and methods for improving skin appearance
CN112423799A (zh)2018-05-092021-02-26约翰·霍普金斯大学用于增强的软组织替代和再生的纳米纤维-水凝胶复合物
CA3099732A1 (en)2018-05-092019-11-14The Johns Hopkins UniversityNanofiber-hydrogel composites for cell and tissue delivery
CN115427032A (zh)2020-03-312022-12-02浙江养生堂天然药物研究所有限公司药物组合及其用途
CN115361945B (zh)2020-03-312024-11-12浙江养生堂天然药物研究所有限公司药物组合及其用途
US20230338345A1 (en)2020-04-232023-10-26Natural Medicine Institute Of Zhejiang Yangshengtang Co., Ltd.Drug combination and use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
DD33788A (es)*
JPS4838158B1 (es)*1970-10-051973-11-15
US4065557A (en)*1974-03-211977-12-27Bayer AktiengesellschaftAmino sugars and their use in improving the meat:fat ratio in animals
DD141832A1 (de)*1978-10-311980-05-21Joachim SchmidtVerfahren und vorrichtung zur herstellung von l-ascorbinsaeure
EP0112332B1 (en)*1982-06-301993-06-16The General Hospital CorporationVitamin d glycosides
JPS60130582A (ja)*1983-12-191985-07-12Takeda Chem Ind Ltd食品用酸化防止剤，アスコルビン酸誘導体およびその製造法
US4822816A (en)*1987-04-101989-04-18Oxycal Laboratories, Inc.Compositions and methods for administering vitamin C
US5137723A (en)*1989-05-191992-08-11Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujoα-Glycosyl-L-ascorbic acid, and its preparation and uses
JP2832848B2 (ja)*1989-10-211998-12-09株式会社林原生物化学研究所結晶２―Ｏ―α―Ｄ―グルコピラノシル―Ｌ―アスコルビン酸とその製造方法並びに用途

Also Published As

Publication numberPublication date
EP0398484A3 (en)1991-02-27
EP0398484B1 (en)1995-05-31
DE69019779D1 (de)1995-07-06
US5767149A (en)1998-06-16
DE69019779T2 (de)1995-12-14
HK111196A (en)1996-07-05
ATE123306T1 (de)1995-06-15
US5137723A (en)1992-08-11
US5616611A (en)1997-04-01
EP0398484A2 (en)1990-11-22
DK0398484T3 (da)1995-07-24

Similar Documents

PublicationPublication DateTitle
ES2075148T3 (es)Acido alfa-glicosil-l-ascorbico, y su preparacion y usos.
SE8602805L (sv)Polysackaridkompositioner, deras framstellning och anvendning
FR2634376B1 (fr)Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
AU607690B2 (en)Use of synthetic sulfated saccharides to enhance wound healing
CA2225797A1 (en)Active principle carriers containing non-ionic surfactants, and uses thereof, particularly in food, cosmetics and pharmaceuticals
ATE227587T1 (de)Kombinierte verwendung von hyaluronsäure und therapeutischen wirkstoffen zur verbesserung des therapeutischen effekts
KR900018130A (ko)α-글리코실-L-아스코르브산, 그 제조방법 및 용도
ATE50926T1 (de)Auf phosphorsaeureester basierende, oberflaechenaktive zusammensetzungen, deren herstellungsverfahren und deren verwendung um wirksame praeparate herzustellen.
GR3030124T3 (en)Derivatives of cyclohexane, preparations containing them and their use
ES485566A1 (es)Procedimiento para la produccion de una substancia que pre- senta actividad bacteriostatica
KR970009581B1 (en)Composition for topical use containing depolymerized deoxyribonucleic acids in the skin and body cosmetic treathent
DE3574109D1 (en)Vaccine against diseases due to micro-organisms such as mycoplasms, preparation thereof and membranes of micro-organisms as active principle
AU6497586A (en)Human manganese superoxide dismutase cDNA and its expression in bacteria and method of recovering enzymatically active human manganese superoxide dismutase
EP0246569A3 (en)Superoxide dismutase derivatives, method of producing same and pharmaceutical composition
EP0310126A3 (en)Derivatives of pyrocatechol-carboxylic acid, their preparation and use as active ingredients in medicines
ATE102019T1 (de)Mittel zur kosmetischen oder pharmazeutischen verwendung.
GB2234973B (en)Aqueous liquid enzyme formulation of proteolytically active enzymes
IL85205A0 (en)Plasmid capable of high level expression in e. coli of soluble mature hil-1beta and derivatives with altered biological activity
JPS5679622A (en)Antitumor pharmaceutical
HUT44786A (en)Process for production of quinazolin-dions, piridopirimidin-dions and medical preparatives containing them as active substance
DE69010518D1 (de)Wässerige Desmopressin-CMC enthaltende Arzneizubereitung.
HUT41235A (en)Pesticide, particularly insecticide compositions and process for preparing benzoyl-carbamides to be applied as active ingredients thereof
HUP9800520A2 (hu)Génexpresszió emlős sejtekben
FR2567402B1 (fr)Nouvelles compositions pharmaceutiques et cosmetiques contenant comme ingredient actif la dihydroxy-1,8 phenyl-10 anthrone-9, et procede de preparation de l'ingredient actif
KR910000131A (ko)생리학적 투여량의 비타민a와 치료학적 활성이 있는 각종 활성소의 군집

Legal Events

DateCodeTitleDescription
FG2ADefinitive protection

Ref document number:398484

Country of ref document:ES
[8]ページ先頭
©2009-2025 Movatter.jp